Team
Pipeline
Platforms
Publications
News & Events
Investors
Careers

Cell Reports

LY-CoV1404 (bebtelovimab) potently neutralizes SARS–CoV–2 variants

Post navigation

Previous: Cell Reports

Search

Recent Posts

Recent Comments

No comments to show.

Archives

No archives to show.

Categories

No categories

Innovation.

About us
Our team

Our pipeline

GPCRs & ion channels
T-cell engagers
Our engine

Presentations & posters
Journal articles
Scientific case studies

In the news
Press kit

Work with us
Current openings

Partner with us

Get in touch

AbCellera
2215 Yukon Street
Vancouver, BC V5Y 0A1
office: 604.559.9005

Legal

Privacy policy